Durham's BioCryst has acquired a Boston drugmaker with a new treatment that executives say has strong potential.
If you’re going to be a growing region, you have to invest in growth. We love our festivals here. It’s a unique part of what ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results